Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting

Kamala Mc Millan Nola, Dick R. Gourley, Tracy S. Portner, Greta K. Gourley, David K. Solomon, Marshall Elam, Bill Regel

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

OBJECTIVES: To identify patients at risk for coronary artery disease (CAD) through a search of a community pharmacy's prescription database, to screen and identify patients with elevated cholesterol and at risk for CAD, to enroll patients in a pharmacist-directed lipid management program, and to evaluate selected clinical and humanistic outcomes. DESIGN: Randomized, pretest-posttest control groups. SETTING: Independent community pharmacy in a suburban metropolitan area. PATIENTS: 51 patients who were not at National Cholesterol Education Program low-density lipoprotein cholesterol (LDL-C) or defined triglyceride goals and who met inclusion criteria. INTERVENTION: Pharmacist-directed lipid management program. MAIN OUTCOME MEASURES: Clinical outcome measures included total cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglyceride levels; achievement of LDL-C goal; and risk factor prediction scores. Humanistic outcome measures included patient satisfaction with pharmaceutical care and patient knowledge of hyperlipidemia. RESULTS: LDL-C was decreased in the pharmacist intervention group (n = 25), compared with an increase in the control group at study end. HDL-C levels increased and triglyceride levels decreased in both groups. Of treatment group patients, 32% achieved their cholesterol goals, compared with 15% of control group patients. Risk factor prediction scores improved in the treatment group and worsened in the control group. The treatment group's hyperlipidemia knowledge scores improved significantly from pretest to posttest. Both treatment and control group patient satisfaction scores for the pharmacist investigator were favorable at study end. CONCLUSION: Both treatment and control patients benefited from participating in this study. Patients enrolled in the lipid management program made greater improvements in their knowledge of hyperlipidemia, risk factor scores, and cholesterol levels.

Original languageEnglish (US)
Pages (from-to)166-173
Number of pages8
JournalJournal of the American Pharmaceutical Association (Washington, D.C. : 1996)
Volume40
Issue number2
DOIs
StatePublished - Jan 1 2000

Fingerprint

Pharmacies
Lipids
LDL Cholesterol
Cholesterol
Pharmacists
Control Groups
Hyperlipidemias
HDL Cholesterol
Triglycerides
Patient Satisfaction
Coronary Artery Disease
Outcome Assessment (Health Care)
Therapeutics
Pharmaceutical Services
Education
Hypercholesterolemia
Prescriptions
Research Personnel
Pharmaceutical Preparations
Databases

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. / Nola, Kamala Mc Millan; Gourley, Dick R.; Portner, Tracy S.; Gourley, Greta K.; Solomon, David K.; Elam, Marshall; Regel, Bill.

In: Journal of the American Pharmaceutical Association (Washington, D.C. : 1996), Vol. 40, No. 2, 01.01.2000, p. 166-173.

Research output: Contribution to journalArticle

Nola, Kamala Mc Millan ; Gourley, Dick R. ; Portner, Tracy S. ; Gourley, Greta K. ; Solomon, David K. ; Elam, Marshall ; Regel, Bill. / Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. In: Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 2000 ; Vol. 40, No. 2. pp. 166-173.
@article{397ec75729ee4f2cb74d05ecb1be4d43,
title = "Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting",
abstract = "OBJECTIVES: To identify patients at risk for coronary artery disease (CAD) through a search of a community pharmacy's prescription database, to screen and identify patients with elevated cholesterol and at risk for CAD, to enroll patients in a pharmacist-directed lipid management program, and to evaluate selected clinical and humanistic outcomes. DESIGN: Randomized, pretest-posttest control groups. SETTING: Independent community pharmacy in a suburban metropolitan area. PATIENTS: 51 patients who were not at National Cholesterol Education Program low-density lipoprotein cholesterol (LDL-C) or defined triglyceride goals and who met inclusion criteria. INTERVENTION: Pharmacist-directed lipid management program. MAIN OUTCOME MEASURES: Clinical outcome measures included total cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglyceride levels; achievement of LDL-C goal; and risk factor prediction scores. Humanistic outcome measures included patient satisfaction with pharmaceutical care and patient knowledge of hyperlipidemia. RESULTS: LDL-C was decreased in the pharmacist intervention group (n = 25), compared with an increase in the control group at study end. HDL-C levels increased and triglyceride levels decreased in both groups. Of treatment group patients, 32{\%} achieved their cholesterol goals, compared with 15{\%} of control group patients. Risk factor prediction scores improved in the treatment group and worsened in the control group. The treatment group's hyperlipidemia knowledge scores improved significantly from pretest to posttest. Both treatment and control group patient satisfaction scores for the pharmacist investigator were favorable at study end. CONCLUSION: Both treatment and control patients benefited from participating in this study. Patients enrolled in the lipid management program made greater improvements in their knowledge of hyperlipidemia, risk factor scores, and cholesterol levels.",
author = "Nola, {Kamala Mc Millan} and Gourley, {Dick R.} and Portner, {Tracy S.} and Gourley, {Greta K.} and Solomon, {David K.} and Marshall Elam and Bill Regel",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1086-5802(16)31060-9",
language = "English (US)",
volume = "40",
pages = "166--173",
journal = "Journal of the American Pharmacists Association : JAPhA",
issn = "1544-3191",
publisher = "American Pharmacists Association",
number = "2",

}

TY - JOUR

T1 - Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting

AU - Nola, Kamala Mc Millan

AU - Gourley, Dick R.

AU - Portner, Tracy S.

AU - Gourley, Greta K.

AU - Solomon, David K.

AU - Elam, Marshall

AU - Regel, Bill

PY - 2000/1/1

Y1 - 2000/1/1

N2 - OBJECTIVES: To identify patients at risk for coronary artery disease (CAD) through a search of a community pharmacy's prescription database, to screen and identify patients with elevated cholesterol and at risk for CAD, to enroll patients in a pharmacist-directed lipid management program, and to evaluate selected clinical and humanistic outcomes. DESIGN: Randomized, pretest-posttest control groups. SETTING: Independent community pharmacy in a suburban metropolitan area. PATIENTS: 51 patients who were not at National Cholesterol Education Program low-density lipoprotein cholesterol (LDL-C) or defined triglyceride goals and who met inclusion criteria. INTERVENTION: Pharmacist-directed lipid management program. MAIN OUTCOME MEASURES: Clinical outcome measures included total cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglyceride levels; achievement of LDL-C goal; and risk factor prediction scores. Humanistic outcome measures included patient satisfaction with pharmaceutical care and patient knowledge of hyperlipidemia. RESULTS: LDL-C was decreased in the pharmacist intervention group (n = 25), compared with an increase in the control group at study end. HDL-C levels increased and triglyceride levels decreased in both groups. Of treatment group patients, 32% achieved their cholesterol goals, compared with 15% of control group patients. Risk factor prediction scores improved in the treatment group and worsened in the control group. The treatment group's hyperlipidemia knowledge scores improved significantly from pretest to posttest. Both treatment and control group patient satisfaction scores for the pharmacist investigator were favorable at study end. CONCLUSION: Both treatment and control patients benefited from participating in this study. Patients enrolled in the lipid management program made greater improvements in their knowledge of hyperlipidemia, risk factor scores, and cholesterol levels.

AB - OBJECTIVES: To identify patients at risk for coronary artery disease (CAD) through a search of a community pharmacy's prescription database, to screen and identify patients with elevated cholesterol and at risk for CAD, to enroll patients in a pharmacist-directed lipid management program, and to evaluate selected clinical and humanistic outcomes. DESIGN: Randomized, pretest-posttest control groups. SETTING: Independent community pharmacy in a suburban metropolitan area. PATIENTS: 51 patients who were not at National Cholesterol Education Program low-density lipoprotein cholesterol (LDL-C) or defined triglyceride goals and who met inclusion criteria. INTERVENTION: Pharmacist-directed lipid management program. MAIN OUTCOME MEASURES: Clinical outcome measures included total cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglyceride levels; achievement of LDL-C goal; and risk factor prediction scores. Humanistic outcome measures included patient satisfaction with pharmaceutical care and patient knowledge of hyperlipidemia. RESULTS: LDL-C was decreased in the pharmacist intervention group (n = 25), compared with an increase in the control group at study end. HDL-C levels increased and triglyceride levels decreased in both groups. Of treatment group patients, 32% achieved their cholesterol goals, compared with 15% of control group patients. Risk factor prediction scores improved in the treatment group and worsened in the control group. The treatment group's hyperlipidemia knowledge scores improved significantly from pretest to posttest. Both treatment and control group patient satisfaction scores for the pharmacist investigator were favorable at study end. CONCLUSION: Both treatment and control patients benefited from participating in this study. Patients enrolled in the lipid management program made greater improvements in their knowledge of hyperlipidemia, risk factor scores, and cholesterol levels.

UR - http://www.scopus.com/inward/record.url?scp=0034153597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034153597&partnerID=8YFLogxK

U2 - 10.1016/S1086-5802(16)31060-9

DO - 10.1016/S1086-5802(16)31060-9

M3 - Article

VL - 40

SP - 166

EP - 173

JO - Journal of the American Pharmacists Association : JAPhA

JF - Journal of the American Pharmacists Association : JAPhA

SN - 1544-3191

IS - 2

ER -